Peptide record

TPDB18069

Z24 Z44 Antibacterial Anticancer Antiviral modified_plain modified
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB18069
Z24 Z44
Antibacterial Anticancer Antiviral
Anti-infective peptides Cancer-related peptides
Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab AI4AVP
modified_plain
Yes
A 24-aa modified multi-activity (Antibacterial, Anticancer, and Antiviral) peptide sequence curated from Peptipedia, ACP740 _ACP240, AntiCP 2.0, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
ALSKALSKALSKALSKALSKALSK-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
24 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antibacterial Activity
Xenopus laevis Activity
Evidence Records 20 records
Evidence 1 Activity

Activity

IC50
IC50=97 µg/ml
Anticancer
97 µg/mL

Target

Lymphoma Cancer
U-937
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50=123 µg/ml
Anticancer
123 µg/mL

Target

Lymphoma Cancer
U-937
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 3 Activity

Activity

IC50
IC50=60 µg/ml
Anticancer
60 µg/mL

Target

Leukemia Cancer
8402
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 4 Activity

Activity

IC50
IC50=83 µg/ml
Anticancer
83 µg/mL

Target

Leukemia Cancer
8402
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 5 Activity

Activity

IC50
IC50=107 µg/ml
Anticancer
107 µg/mL

Target

Hematopoietic Cancer
SSKT-1
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 6 Activity

Activity

IC50
IC50=109 µg/ml
Anticancer
109 µg/mL

Target

Hematopoietic Cancer
SSKT-1
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 7 Activity

Activity

IC50
IC50=115 µg/ml
Anticancer
115 µg/mL

Target

Brain Tumor
Daudi
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 8 Activity

Activity

IC50
IC50=143 µg/ml
Anticancer
143 µg/mL

Target

Leukemia Cancer
Daudi
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 9 Activity

Activity

IC50
IC50=80 µg/ml
Anticancer
80 µg/mL

Target

Leukemia Cancer
MLA
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 10 Activity

Activity

IC50
IC50=102 µg/ml
Anticancer
102 µg/mL

Target

Leukemia Cancer
MLA
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 11 Activity

Activity

IC50
IC50=64 µg/ml
Anticancer
64 µg/mL

Target

Lymphoma Cancer
Raji
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 12 Activity

Activity

IC50
IC50=72 µg/ml
Anticancer
72 µg/mL

Target

Lymphoma Cancer
Raji
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 13 Activity

Activity

IC50
IC50=98 µg/ml
Anticancer
98 µg/mL

Target

Leukemia Cancer
K-562
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 14 Activity

Activity

IC50
IC50=112 µg/ml
Anticancer
112 µg/mL

Target

Leukemia Cancer
K-562
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 15 Activity

Activity

Not Available
Anticancer

Target

Ewing sarcoma
CHP-100
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 16 Activity

Activity

Not Available
Anticancer

Target

Ewing sarcoma
CHP-100
Blood

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 17 Activity

Activity

Not Available
Anticancer

Target

Breast Cancer
MCF-7
Breast

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 18 Activity

Activity

Not Available
Anticancer

Target

Breast Cancer
MCF-7
Breast

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 19 Activity

Activity

Not Available
Anticancer

Target

Prostate Cancer
PC-3
Prostate

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990
Evidence 20 Activity

Activity

Not Available
Anticancer

Target

Prostate Cancer
PC-3
Prostate

Assay & Model

Trypan blue assay
72-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1990